4.7 Article

Effect of remdesivir post-exposure prophylaxis and treatment on pathogenesis of measles in rhesus macaques

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Public, Environmental & Occupational Health

Vaccination Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten — United States, 2021–22 School Year

Ranee Seither et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2023)

Article Immunology

Clinical Improvement, Outcomes, Antiviral Activity, and Costs Associated With Early Treatment With Remdesivir for Patients With Coronavirus Disease 2019 (COVID-19)

Carlos K. H. Wong et al.

Summary: Early initiation of remdesivir in hospitalized patients with moderate COVID-19, who do not require oxygen therapy, is associated with significantly shorter time to clinical improvement, low viral load and positive IgG antibody, a shorter length of hospital stay, and a significantly lower risk of in-hospital death.

CLINICAL INFECTIOUS DISEASES (2022)

Review Medicine, General & Internal

COVID-19 Rebound After Paxlovid Treatment: A Case Series and Review of Literature

Shatha Alshanqeeti et al.

Summary: Since the declaration of COVID-19 as a pandemic, Paxlovid has been developed as an antiviral therapy for non-hospitalized symptomatic patients. However, there have been reports of symptom relapse after treatment with Paxlovid.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Article Immunology

PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors

Elizabeth S. Higgs et al.

Summary: This study aimed to investigate the impact of remdesivir on persistent Ebola virus RNA in semen. The results showed similar mean assay negativity rates between the remdesivir and placebo arms during the treatment phase, but higher rates in the remdesivir arm during the follow-up phase. Overall, the 5-day regimen of remdesivir demonstrated good tolerability and reduction in seminal Ebola virus RNA persistence.

CLINICAL INFECTIOUS DISEASES (2021)

Review Virology

Measles immunity and immunosuppression

Diane E. Griffin

Summary: The effects of measles on the immune system are partially understood. The virus replicates in lymphoid tissue, triggering immune responses to establish lifelong immunity but also increasing susceptibility to other infections.

CURRENT OPINION IN VIROLOGY (2021)

Article Microbiology

Therapeutic targeting of measles virus polymerase with ERDRP-0519 suppresses all RNA synthesis activity

Robert M. Cox et al.

Summary: The study characterized a clinical candidate small-molecule MeV polymerase inhibitor, demonstrating a unique mechanism of action unlike all other known mononegavirus polymerase inhibitors. The compound stabilizes a pre-initiation conformation of the viral polymerase complex, preventing template RNA accommodation. This insight can serve as a blueprint for expanding indication spectrum through targeted drug discovery.

PLOS PATHOGENS (2021)

News Item Medicine, General & Internal

Measles outbreaks likely as covid pandemic leaves millions of world's children unvaccinated, WHO warns

Ingrid Torjesen

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Multidisciplinary Sciences

Small-molecule polymerase inhibitor protects non-human primates from measles and reduces shedding

Kevin Wittwer et al.

Summary: The study demonstrates that the orally bioavailable small-molecule polymerase inhibitor ERDRP-0519 can prevent measles disease in squirrel monkeys and reduce virus shedding, potentially aiding outbreak control and augmenting measles virus eradication.

NATURE COMMUNICATIONS (2021)

Review Immunology

What Is the Evidence to Support a Correlate of Protection for Measles? A Systematic Review

Shelly Bolotin et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Article Biochemistry & Molecular Biology

The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus

Calvin J. Gordon et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Article Multidisciplinary Sciences

Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

Emmie de Wit et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Infectious Diseases

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

Adarsh Bhimraj et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Immunology

Remdesivir (GS-5734) Is Efficacious in Cynomolgus Macaques Infected With Marburg Virus

Danielle P. Porter et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Review Virology

Measles Resurgence and Drug Development

Richard K. Plemper

CURRENT OPINION IN VIROLOGY (2020)

Article Medicine, General & Internal

Compassionate Use of Remdesivir for Patients with Severe Covid-19

J. Grein et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

Brandi N. Williamson et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action

Egor P. Tchesnokov et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Article Multidisciplinary Sciences

Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases

Michael K. Lo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Editorial Material Medicine, General & Internal

A living WHO guideline on drugs for covid-19

Francois Lamontagne et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Medicine, Research & Experimental

Association of persistent wild-type measles virus RNA with long-term humoral immunity in rhesus macaques

Ashley N. Nelson et al.

JCI INSIGHT (2020)

Article Cell Biology

Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge

Michael K. Lo et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Article Medicine, General & Internal

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

Sabue Mulangu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Multidisciplinary Sciences

GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses

Michael K. Lo et al.

SCIENTIFIC REPORTS (2017)

Article Multidisciplinary Sciences

Evolution of T Cell Responses during Measles Virus Infection and RNA Clearance

Ashley N. Nelson et al.

SCIENTIFIC REPORTS (2017)

Article Multidisciplinary Sciences

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

Travis K. Warren et al.

NATURE (2016)

Review Medicine, General & Internal

Post-exposure passive immunisation for preventing measles

Megan K. Young et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)

Article Multidisciplinary Sciences

Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics

Wen-Hsuan W. Lin et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Multidisciplinary Sciences

Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles

CH Pan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Medicine, General & Internal

Vitamin A for treating measles in children

Y. Huiming et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)